Supernus Pharmaceuticals (SUPN) Net Margin Growth (1y) (2012 - 2025)
Supernus Pharmaceuticals (SUPN) Net Margin Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 372.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -82.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -538.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -2,930.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2,292.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -146.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2,359.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1,181.00 |
| 10 | Supernus Pharmaceuticals | 2.63 Bn | 2.24 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,076.00 |
| Sep 30, 2025 | -4,542.00 |
| Jun 30, 2025 | 177.00 |
| Mar 31, 2025 | -798.00 |
| Dec 31, 2024 | 811.00 |
| Sep 30, 2024 | 3,234.00 |
| Jun 30, 2024 | 1,244.00 |
| Mar 31, 2024 | -1,092.00 |
| Dec 31, 2023 | -1,455.00 |
| Sep 30, 2023 | -1,139.00 |
| Jun 30, 2023 | -521.00 |
| Mar 31, 2023 | -580.00 |
| Dec 31, 2022 | 1,371.00 |
| Sep 30, 2022 | -1,354.00 |
| Jun 30, 2022 | -1,219.00 |
| Mar 31, 2022 | 1,245.00 |
| Dec 31, 2021 | -1,990.00 |
| Sep 30, 2021 | -1,126.00 |
| Jun 30, 2021 | -1,057.00 |
| Mar 31, 2021 | -1,831.00 |